Raymond James & Associates’s Primerica PRI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | $32.2M | Buy |
121,349
+5,323
| +5% | +$1.34M | 0.02% | 596 |
|
|
2024
Q2 | $27.4M | Sell |
116,026
-85
| -0.1% | -$19.3K | 0.02% | 632 |
|
|
2024
Q1 | $29.4M | Sell |
116,111
-42
| -0% | -$9.93K | 0.02% | 601 |
|
|
2023
Q4 | $23.9M | Sell |
116,153
-2,971
| -2% | -$607K | 0.02% | 657 |
|
|
2023
Q3 | $23.1M | Sell |
119,124
-716
| -0.6% | -$147K | 0.02% | 616 |
|
|
2023
Q2 | $23.7M | Sell |
119,840
-3,249
| -3% | -$597K | 0.02% | 624 |
|
|
2023
Q1 | $21.2M | Buy |
123,089
+6,392
| +5% | +$1.05M | 0.02% | 655 |
|
|
2022
Q4 | $16.5M | Sell |
116,697
-4,557
| -4% | -$635K | 0.02% | 751 |
|
|
2022
Q3 | $15M | Buy |
121,254
+111,277
| +1,115% | +$14.1M | 0.02% | 746 |
|
|
2022
Q2 | $1.19M | Sell |
9,977
-1,122
| -10% | -$141K | ﹤0.01% | 2323 |
|
|
2022
Q1 | $1.52M | Sell |
11,099
-115,369
| -91% | -$16.4M | ﹤0.01% | 2319 |
|
|
2021
Q4 | $19.4M | Sell |
126,468
-1,877
| -1% | -$298K | 0.02% | 758 |
|
|
2021
Q3 | $19.7M | Sell |
128,345
-606
| -0.5% | -$90.2K | 0.02% | 717 |
|
|
2021
Q2 | $19.7M | Sell |
128,951
-1,406
| -1% | -$222K | 0.02% | 714 |
|
|
2021
Q1 | $19.3M | Sell |
130,357
-3,363
| -3% | -$482K | 0.02% | 683 |
|
|
2020
Q4 | $17.9M | Buy |
133,720
+3,088
| +2% | +$388K | 0.02% | 667 |
|
|
2020
Q3 | $14.8M | Sell |
130,632
-37,711
| -22% | -$4.58M | 0.02% | 669 |
|
|
2020
Q2 | $19.6M | Buy |
168,343
+2,086
| +1% | +$222K | 0.03% | 523 |
|
|
2020
Q1 | $14.7M | Sell |
166,257
-6,033
| -4% | -$690K | 0.02% | 573 |
|
|
2019
Q4 | $22.5M | Buy |
172,290
+7,054
| +4% | +$911K | 0.03% | 526 |
|
|
2019
Q3 | $21M | Buy |
165,236
+6,457
| +4% | +$779K | 0.03% | 523 |
|
|
2019
Q2 | $19M | Buy |
158,779
+2,369
| +2% | +$293K | 0.03% | 555 |
|
|
2019
Q1 | $19.1M | Buy |
156,410
+2,615
| +2% | +$301K | 0.03% | 532 |
|
|
2018
Q4 | $15M | Sell |
153,795
-8,522
| -5% | -$948K | 0.03% | 576 |
|
|
2018
Q3 | $19.6M | Buy |
162,317
+18,059
| +13% | +$2.09M | 0.03% | 536 |
|
|
2018
Q2 | $14.4M | Buy |
144,258
+8,292
| +6% | +$812K | 0.02% | 646 |
|
|
2018
Q1 | $13.1M | Buy |
135,966
+9,013
| +7% | +$905K | 0.02% | 643 |
|
|
2017
Q4 | $12.9M | Buy |
126,953
+7,300
| +6% | +$696K | 0.02% | 645 |
|
|
2017
Q3 | $9.76M | Buy |
119,653
+6,183
| +5% | +$483K | 0.02% | 755 |
|
|
2017
Q2 | $8.6M | Buy |
113,470
+10,543
| +10% | +$827K | 0.02% | 778 |
|
|
2017
Q1 | $8.46M | Buy |
102,927
+1,032
| +1% | +$80.5K | 0.02% | 770 |
|
|
2016
Q4 | $7.05M | Buy |
101,895
+1,470
| +1% | +$93.5K | 0.02% | 814 |
|
|
2016
Q3 | $5.33M | Buy |
100,425
+24,568
| +32% | +$1.36M | 0.01% | 919 |
|
|
2016
Q2 | $4.34M | Buy |
75,857
+2,139
| +3% | +$111K | 0.01% | 928 |
|
|
2016
Q1 | $3.28M | Sell |
73,718
-3,759
| -5% | -$162K | 0.01% | 1030 |
|
|
2015
Q4 | $3.66M | Buy |
+77,477
| New | +$3.79M | 0.01% | 957 |
|
|
2014
Q2 | – | Sell |
-36,179
| Closed | -$1.7M | – | 2216 |
|
|
2014
Q1 | $1.7M | Buy |
+36,179
| New | +$1.61M | 0.01% | 1126 |
|
Other funds holding PRI
BWA
BAM
AM
Raymond James & Associates's PRI Position: Q3 2024 in Review
Raymond James & Associates increased its Primerica (PRI) stake by 4.6% in Q3 2024, buying an estimated $1.34M and bringing the position to 121,349 shares worth $32.2M. The position accounts for 0.02% of the portfolio, ranked #596.
Raymond James & Associates first reported a position in PRI in Q1 2014 and has held it in 37 quarters since. 449 funds tracked by Wall St. Rank hold PRI as of Q3 2024.
- Raymond James & Associates held 121,349 shares of Primerica worth $32.2M as of Q3 2024.
- Raymond James & Associates bought 5,323 Primerica shares in Q3 2024, an estimated $1.34M.
- Primerica made up 0.02% of Raymond James & Associates's portfolio in Q3 2024, its #596 holding.
- Raymond James & Associates first reported a position in Primerica in Q1 2014 and has held it in 37 quarters since.
- 449 funds tracked by Wall St. Rank held Primerica as of Q3 2024.
Based on Raymond James & Associates's 13F filing for Q3 2024, filed 18 Oct 2024.